Bookmark

Add to MyYahoo RSS

DePuy Orthopaedics News

News on DePuy Orthopaedics (Ticker: JNJ) continually updated from thousands of sources around the net.

Friday | BioSpace

Johnson & Johnson Starts Construction On $300 Million China Plant

For J&J, the new facility is its biggest single investment in a plant and its largest production facility .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Friday | PR-inside.com

Belgium digestive remedies market: Janssen-Cilag the dominant industry player during 2012

Janssen-Cilag was the undisputed leader in a fragmented competitive environment in the Belgium digestive remedies market in 2012.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thu Apr 17, 2014

Examiner.com

How your green business can encourage consumers to recycle

Nearly three-quarters of consumers consistently recycle in the home, but only about half do so in rooms beyond the kitchen.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Argus Increases Johnson & Johnson Price Target to $116.00

The firm currently has a "buy" rating on the stock. Argus' target price suggests a potential upside of 16.94% from the stock's previous close.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Apr 16, 2014

The Motley Fool

Is Johnson & Johnson's Dividend Unbeatable?

Major health-care stocks out of big pharma and medical devices offer great dividends, but few offer the strength and reliability of sector colossus Johnson & Johnson .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

KHOU-TV Houston

Smartphone apps to help patients take their meds

Several smartphone apps are available to help patients take their medications as prescribed.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Apr 15, 2014

Investor's Business Daily

Major Averages Reverse Early Losses In Higher Volume

Tuesday was shaping up to be another ugly day for the stock market, but major averages recovered impressively and closed near highs on a busy day of headline flow.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Investopedia

Earnings Outlook is the Key Factor - Ahead of Wall Street

The benign inflation reading and a soft Empire State manufacturing survey are the only notable economic reports today.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

PR-inside.com

Taiwan baby products market: Johnson & Johnson and BA1 4bchen the...

These include Johnson & Johnson, BA1 4bchen, Sebamed, Chicco and Pigeon, which together accounted for 71% of total sales in 2012.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Forbes.com

Johnson & Johnson Profit Jumps As Prescription Drug Sales Surge And Outlook Increases

As a result of the strong earnings figures, shares of Johnson & Johnson are trading higher Tuesday and the company has lifted its full-year outlook.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Norwalk Citizen News

J&J Q1 net up 8 percent on sales jump, lower costs

Johnson & Johnson says its first-quarter profit rose 8 percent, because of restrained costs and a big jump in prescription drug sales.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Apr 14, 2014

BioSpace

Johnson & Johnson Innovation Center Joins Advance Drug Discovery Effort

The Scripps Research Institute has joined with Johnson & Johnson Innovation Center and other partners to launch a new drug discovery effort designed to translate early-stage biomedical research projects into new treatments.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

AmericanBankingNews.com

Johnson & Johnson (JNJ) to Release Quarterly Earnings on Tuesday

Johnson & Johnson is scheduled to be announcing its Q114 earnings results on Tuesday, April 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Fri Apr 11, 2014

Forbes.com

Forbes Earnings Preview: Johnson & Johnson

Johnson & Johnson reports its first-quarter earnings on Tuesday, April 15, 2014, and the consensus earnings per share estimate is $1.48 per share.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Apr 08, 2014

Environmental Leader

Avon Ditches Triclosan

Avon has announced plans to phase out the antibacterial chemical triclosan from its cosmetic and personal care products, the company has announced.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Apr 02, 2014

Adweek

Why Johnson & Johnson Treasures BabyCenter's Data

Johnson & Johnson has improved on its ability to target its advertising and develop brand strategies thanks to some internal initiatives .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Apr 01, 2014

OutputLinks

May 13: Creating a Winning Digital Experience

Every organization wants to offer its customers a great digital experience, but putting all the pieces together to support a valid business model is a challenge.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Knowledge Management, Medical Equipment, Hospital Administration, St Peters Health Care Services

Seeking Alpha

What Can Investors Expect Of Johnson & Johnson's Dividend Going Forward?

Johnson & Johnson has shown a strong commitment to returning capital to shareholders with a 51-year streak of dividend increases.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Mar 31, 2014

Wall Street Journal

Johnson & Johnson Accepts Bid for...

Johnson & Johnson said Monday that it accepted Carlyle Group LP's offer to acquire its ortho-clinical diagnostics business for about $4 billion.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services, Opinion

Fox News

J&J Agrees to Sell Ortho Arm to Carlyle for $4B

Johnson & Johnson announced Monday it accepted a binding offer from Carlyle Group to acquire its Ortho-Clinical Diagnostics business for about $4 billion.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, OrthoClinical Diagnostics, Medical Equipment, Healthcare Industry, Hospital Administration, St Peters Health Care Services

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••